2023
DOI: 10.1111/bjh.18959
|View full text |Cite
|
Sign up to set email alerts
|

First use of ibrutinib for the treatment of post‐transplant central nervous system graft‐versus‐host disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 12 publications
0
0
0
Order By: Relevance